A Study to Evaluate the Safety, Tolerability and PK of SK-08

NCT07021157 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Kidney Disease(CKD)

Interventions

DRUG: SK-08
DRUG: Placebo

Sponsor

Consun Pharmaceutical Group